Glenn MacLean

1.8k total citations
14 papers, 1.4k citations indexed

About

Glenn MacLean is a scholar working on Molecular Biology, Genetics and Immunology. According to data from OpenAlex, Glenn MacLean has authored 14 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 8 papers in Genetics and 3 papers in Immunology. Recurrent topics in Glenn MacLean's work include Retinoids in leukemia and cellular processes (7 papers), Genetic and Clinical Aspects of Sex Determination and Chromosomal Abnormalities (6 papers) and Acute Myeloid Leukemia Research (2 papers). Glenn MacLean is often cited by papers focused on Retinoids in leukemia and cellular processes (7 papers), Genetic and Clinical Aspects of Sex Determination and Chromosomal Abnormalities (6 papers) and Acute Myeloid Leukemia Research (2 papers). Glenn MacLean collaborates with scholars based in Canada, France and United States. Glenn MacLean's co-authors include Martin Petkovich, Pierre Chambon, Pascal Dollé, Suzan Abu–Abed, Hui Li, Stuart H. Orkin, Daniel Metzger, Frederick J. Livesey, Peter Kirwan and Yichen Shi and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Blood and PLoS ONE.

In The Last Decade

Glenn MacLean

14 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Glenn MacLean Canada	13	1.1k	568	195	160	158	14	1.4k
Michelle L. Brinkmeier United States	21	916 0.8×	488 0.9×	85 0.4×	97 0.6×	85 0.5×	44	1.5k
Louise Deltour United States	19	1.3k 1.2×	552 1.0×	34 0.2×	49 0.3×	322 2.0×	30	2.0k
Suzan Abu–Abed Canada	9	1.3k 1.2×	607 1.1×	73 0.4×	37 0.2×	219 1.4×	9	1.5k
A. Gansmüller France	19	687 0.6×	307 0.5×	189 1.0×	212 1.3×	93 0.6×	30	1.4k
Hitoshi Onoue Japan	17	1.1k 1.0×	114 0.2×	70 0.4×	77 0.5×	132 0.8×	27	1.6k
Kathleen M. Scully United States	14	1.4k 1.3×	670 1.2×	71 0.4×	146 0.9×	145 0.9×	17	2.1k
Ya‐Lin Huang Germany	14	1.8k 1.7×	302 0.5×	67 0.3×	24 0.1×	89 0.6×	18	2.2k
Poul Hyttel Denmark	27	1.6k 1.5×	509 0.9×	743 3.8×	237 1.5×	74 0.5×	104	2.3k
Tim Wintermantel Germany	15	439 0.4×	419 0.7×	109 0.6×	436 2.7×	139 0.9×	20	1.2k
Juan Olate Chile	23	1.4k 1.3×	188 0.3×	128 0.7×	103 0.6×	74 0.5×	56	1.9k

Countries citing papers authored by Glenn MacLean

Since Specialization

Citations

This map shows the geographic impact of Glenn MacLean's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Glenn MacLean with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Glenn MacLean more than expected).

Fields of papers citing papers by Glenn MacLean

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Glenn MacLean. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Glenn MacLean. The network helps show where Glenn MacLean may publish in the future.

Co-authorship network of co-authors of Glenn MacLean

This figure shows the co-authorship network connecting the top 25 collaborators of Glenn MacLean. A scholar is included among the top collaborators of Glenn MacLean based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Glenn MacLean. Glenn MacLean is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

MacLean, Glenn, et al.. (2018). Downregulation of Endothelin Receptor B Contributes to Defective B Cell Lymphopoiesis in Trisomy 21 Pluripotent Stem Cells. Scientific Reports. 8(1). 8001–8001. 15 indexed citations

Pittermann, Erik, Nico Lachmann, Glenn MacLean, et al.. (2017). Gene correction of HAX1 reversed Kostmann disease phenotype in patient-specific induced pluripotent stem cells. Blood Advances. 1(14). 903–914. 17 indexed citations

MacLean, Glenn, Tobias Menne, Guoji Guo, et al.. (2012). Altered hematopoiesis in trisomy 21 as revealed through in vitro differentiation of isogenic human pluripotent cells. Proceedings of the National Academy of Sciences. 109(43). 17567–17572. 107 indexed citations

Shi, Yichen, Peter Kirwan, James Smith, et al.. (2012). A Human Stem Cell Model of Early Alzheimer’s Disease Pathology in Down Syndrome. Science Translational Medicine. 4(124). 124ra29–124ra29. 242 indexed citations

MacLean, Glenn, Tobias Menne, In‐Hyun Park, George Q. Daley, & Stuart H. Orkin. (2011). Altered Hematopoiesis in Trisomy 21 As Revealed Through In Vitro Differentiation of Isogenic Human Pluripotent Cells. Blood. 118(21). 921–921. 1 indexed citations

Pennimpede, Tracie, Don Cameron, Glenn MacLean, & Martin Petkovich. (2010). Analysis of Cyp26b1/Rarg compound-null mice reveals two genetically separable effects of retinoic acid on limb outgrowth. Developmental Biology. 339(1). 179–186. 24 indexed citations

Pennimpede, Tracie, Don Cameron, Glenn MacLean, et al.. (2010). The role of CYP26 enzymes in defining appropriate retinoic acid exposure during embryogenesis. Birth Defects Research Part A Clinical and Molecular Teratology. 88(10). 883–894. 118 indexed citations

Li, Hui, Glenn MacLean, Don Cameron, Margaret Clagett‐Dame, & Martin Petkovich. (2009). Cyp26b1 Expression in Murine Sertoli Cells Is Required to Maintain Male Germ Cells in an Undifferentiated State during Embryogenesis. PLoS ONE. 4(10). e7501–e7501. 73 indexed citations

MacLean, Glenn, Pascal Dollé, & Martin Petkovich. (2009). Genetic disruption of CYP26B1 severely affects development of neural crest derived head structures, but does not compromise hindbrain patterning. Developmental Dynamics. 238(3). 732–745. 66 indexed citations

10.

MacLean, Glenn, Hui Li, Daniel Metzger, Pierre Chambon, & Martin Petkovich. (2007). Apoptotic Extinction of Germ Cells in Testes of Cyp26b1 Knockout Mice. Endocrinology. 148(10). 4560–4567. 221 indexed citations

11.

Loudig, Olivier, et al.. (2005). Transcriptional co-operativity between distant retinoic acid response elements in regulation ofCyp26A1inducibility. Biochemical Journal. 392(1). 241–248. 107 indexed citations

12.

Abu–Abed, Suzan, Pascal Dollé, Daniel Metzger, et al.. (2003). Developing with lethal RA levels: genetic ablation ofRargcan restore the viability of mice lackingCyp26a1. Development. 130(7). 1449–1459. 65 indexed citations

13.

Abu–Abed, Suzan, Glenn MacLean, Valérie Fraulob, et al.. (2002). Differential expression of the retinoic acid-metabolizing enzymes CYP26A1 and CYP26B1 during murine organogenesis. Mechanisms of Development. 110(1-2). 173–177. 150 indexed citations

14.

MacLean, Glenn, Suzan Abu–Abed, Pascal Dollé, et al.. (2001). Cloning of a novel retinoic-acid metabolizing cytochrome P450, Cyp26B1, and comparative expression analysis with Cyp26A1 during early murine development. Mechanisms of Development. 107(1-2). 195–201. 183 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact